Diuretic resistance
Formal Definition
A state in which the expected diuretic response is diminished or lost due to activation of compensatory mechanisms (sodium retention distal to the site of diuretic action, "braking phenomenon"), chronic kidney disease, hypoalbuminemia, or concurrent NSAID use; clinically manifests as persistent edema and volume overload despite escalating diuretic doses; addressed by combining diuretics acting at different nephron sites ("sequential nephron blockade"), adding a thiazide to a loop diuretic, or using a high-dose continuous infusion rather than intermittent boluses.
How It's Used on the Ward
"Diuretic resistance" — the patient is on high doses of Lasix but still swelling up; the kidneys have adapted and are holding on to sodium despite the diuretic; the fix is usually to combine a thiazide (acting on the distal tubule) with the loop diuretic or give the loop as a continuous drip instead of pills.
Example
""65-year-old woman with CHF, EF 25%, resistant edema despite furosemide 160mg twice daily, serums creatinine stable at 1.1. 24h urine sodium 185 mEq (on a low sodium diet, should be <100 if diuretics were working). Diagnosis: diuretic resistance with distal tubule sodium retention ("braking phenomenon"). Added metolazone 5mg 30 minutes before furosemide doses (sequential nephron blockade — metolazone blocks sodium reabsorption in distal tubule, the site the loop diuretic leaves behind when it stops working). 48h later: weight down 4 kg, 24h urine sodium now 42 mEq, edema significantly improved.""
Clinical Context
Mechanism of resistance: acute tolerance to loop diuretics develops within days ("braking phenomenon" — hypertrophy of distal tubule cells leads to increased sodium reabsorption after loop diuretic blocks the thick ascending limb). Other contributors: CKD (reduced GFR → less filtered load), hypoalbuminemia (reduced delivery of diuretic to its site of action), NSAIDs (block prostaglandin-mediated renal effects of diuretics), bowel edema (impaired absorption of oral diuretics). Strategies: (1) Double therapy: add thiazide to loop diuretic (sequential nephron blockade — thiazide blocks distal tubule sodium reabsorption that increases when loop is blocked). (2) Triple therapy: add amiloride or spironolactone (blocks ENaC in collecting duct). (3) High-dose continuous infusion: furosemide 10-20mg/h IV (better than bolus, avoids "rebound sodium retention" between doses). (4) Ultrafiltration for refractory cases. Note: adding thiazide to loop diuretic should be used for short periods (days) — chronic combined use risks severe hyponatremia and hypokalemia.